ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Animal models"

  • Abstract Number: 52 • 2018 ACR/ARHP Annual Meeting

    Interferon-Alpha Protects Against Pain and Joint Damages in Experimental Arthritis and Is Associated with Expansion of Highly Suppressive Regulatory T Lymphocytes in Protected Mice and in Tocilizumab-Treated Rheumatoid Arthritis Patients

    Matthieu Ribon1, Roxane Hervé2, Delphine Lemeiter2, Katarzyna Matyja1, François Santinon1, Darragh Duffy3, Ken Tsumiyama4, Shunichi Shiozawa5, Marie-Christophe Boissier6, Natacha Bessis2 and Patrice Decker1, 1Inserm UMR 1125, Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 2Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 3Institut Pasteur, Paris, Paris, France, 4Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan, 5Institute for Rheumatic Diseases, Nagahama, Japan, 6Rheumatology Department, AP-HP, Avicenne Hospital, Bobigny, France

    Background/Purpose: Type I interferons (IFN-I) can be both anti- and pro-inflammatory. Among them, IFN-α inhibits normal Th17 differentiation, whereas it is pathogenic in lupus. The…
  • Abstract Number: 1823 • 2018 ACR/ARHP Annual Meeting

    Loss of Synovial Tissue Resident Macrophages Permits Monocyte to Macrophage Differentiation and Inflammation in Hupo Mice

    Qi Quan Huang1, Renee E. Doyle2, Alexander Misharin3, Shang-Yang Chen4, Deborah R. Winter5 and Richard M. Pope2, 1Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine/pulmonary, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, chicago, IL, 5Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: We established a mouse model (HUPO) by deletion of Flip in CD11c+ cells that spontaneously develops erosive inflammatory arthritis resembling rheumatoid arthritis (RA). Since…
  • Abstract Number: 54 • 2018 ACR/ARHP Annual Meeting

    In a Macaque Model of RA By Immunization with Citrullinated Peptides, the Valine in the 11 Position of the DRB1 Molecule Has Greater Impacts on T-Cell Response to Citrullinated Peptides Than the 70-74 Position in the Shared Epitope

    Samuel Bitoun1, Pierre Roques2, Roger Le Grand3 and Xavier Mariette4, 1INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicêtre, France, 2Immunology of viral infections and autoimmune diseases, IDMIT Infrastructure CEA - Université Paris Sud - INSERM U1184, Fontenay-Aux-Roses,, France, 3Immunology of viral infections and autoimmune diseases, IDMIT Infrastructure CEA - Université Paris Sud - INSERM U1184, Fontenay-Aux-Roses, France, 4Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France

    Background/Purpose: Among genetic risk factors of RA, HLA class II molecules confers the highest risk of ACPA positive RA. The shared epitope (SE) hypothesis that…
  • Abstract Number: 1825 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Associated Haploinsufficiency in PTPN2 Enhances Severity of IL-17 Mediated Autoimmune Arthritis

    Mattias N. D. Svensson1, Karen M. Doody2, Shen Yang3, Dennis J. Wu4, Cristiano Sacchetti5, Isabelle Aubry6, Piotr Mydel7, Mitchell Kronenberg8, Michel L. Tremblay9 and Nunzio Bottini2, 1Department of Medicine, University of California San Diego, La Jolla, CA, 2Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 3Medicine, University of California San Diego, La Jolla, CA, 4University of California San Diego, San Diego, CA, 5Rheumatology, University of California San Diego, La Jolla, CA, 6Biochemistry, McGill University, Montreal, QC, Canada, 7University of Bergen, Bergen, Norway, 8Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 9Biochemistry, McGill University, Montréal, QC, Canada

    Background/Purpose: Genetic polymorphisms at the PTPN2 locus, which encodes the tyrosine phosphatase TC-PTP, cause reduced gene expression and are linked to rheumatoid arthritis (RA). PTPN2…
  • Abstract Number: 55 • 2018 ACR/ARHP Annual Meeting

    Adipose Derived Stem Cell Suppressed Synovial Inflammation and Repaired Cartilage Destruction in Rheumatoid Arthritis Model Mice

    Tadashi Okano1, Kentaro Inui2, Hideki Ueyama3, Kumi Orita3, Tatsuya Koike4 and Hiroaki Nakamura2, 1Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 3Osaka City University Graduate School of Medicine, Osaka, Japan, 4Center for Senile Degenerative Disorders, Osaka City University Graduate School of Medicine, Osaka, Japan

    Background/Purpose: Adipose derived stem cell (ADSC) is one of the stem cells produced by adipose tissue which can be collected easily and in large quantities.…
  • Abstract Number: 1826 • 2018 ACR/ARHP Annual Meeting

    From Cancer to Autoimmunity : A New Model of Rheumatoid Arthritis Emerging from a Constitutional Genetic Approach Used in Low Penetrance Cancers

    Geraldine Falgarone1,2, Morad El Bouchtaoui3, Marcio Do Cruzeiro4, Christophe Leboeuf5,6,7, Irmine Loisel-Ferreira5,6, Carèle Frédonie7, Chrystophe Ferreira8, Rachida Ait El Far5, Marc Espié9, Bruno Cassinat10, Jean-Jacques Kiladjian11, Jean-Paul Feugeas12,13, Anne Janin5,6,14 and Guilhem Bousquet2,5,15, 1HUPSSD, Avicenne Hospital, Rheumatology, APHP, Bobigny, France, 2Paris 13 University, SMBH, Bobigny, France, 3INSERM UMR-S 1165, PARIS, France, 4Plateforme de Recombinaison Homologue, Institut Cochin, INSERM U1016, Paris, France, 5INSERM UMR-S 1165, Paris, France, 6Université Paris Diderot, Paris, France, 7INSERM U944, Paris, France, 8Plateforme ANIMA5, Université Paris Descartes, Paris, France, 9Centre des Maladies du Sein, APHP, Hôpital Saint-Louis, Paris, France, 10Laboratoire de BIologie Cellulaire, APHP, Hôpital Saint-Louis, Paris, France, 11Centre d'Inverstigation Clinique, APHP, Hôpital Saint-Louis, Paris, France, 12INSERM U1137, Paris, France, 13Département de Biologie, Université Franche-Comté, Besançon, France, 14Service de Pathologie, APHP, Hôpital Saint-Louis, Paris, France, 15Service d'Oncologie médicale, APHP, Hôpital Avicenne, Bobigny, France

    Background/Purpose: High-speed technologies for genome sequencing have completely changed the study of disease genetics, but with limited knowledge of the functional value of most genetic…
  • Abstract Number: 63 • 2018 ACR/ARHP Annual Meeting

    TNF-α Blockade Incompletely Reverses Inflammatory Pulmonary Pathology in the TNF-Transgenic Mouse Model of Rheumatoid Arthritis

    Emily Wu1, Richard Bell2, Edward Schwarz3 and Homaira Rahimi4, 1Department of Immunology, Microbiology, and Virology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Orthopedeatrics, University of Rochester, Rochester, NY, 4Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Interstitial lung disease (ILD) is a significant contributor to rheumatoid arthritis (RA) mortality, yet its pathogenesis remains enigmatic. One theory posits that initial inflammatory…
  • Abstract Number: 1893 • 2018 ACR/ARHP Annual Meeting

    Indoleamine-2,3-Dioxygenase in Murine and Human Systemic Lupus Erythematosus

    Zev Sthoeger1,2, Amir Sharabi3, Heidy zinger1, ilan asher4 and edna mozes1, 1Department of Immunology, The Weizmann institute of Science, Rehovot, Israel, 2Department of Allergy and Clinical Immunology, Kaplan Medical Center,, Rehovot, Israel, 3Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 4Department of Allergy and Clinical Immunology, Kaplan Medical Center, Rehovot, Israel

    Background/Purpose: Indoleamine-2,3-dioxygenase (IDO) is a tryptophan catabolizing enzyme which plays a role in immune regulation and in the pathogenesis of autoimmune disorders. Increased IDO activity…
  • Abstract Number: 144 • 2018 ACR/ARHP Annual Meeting

    Small Molecule Inhibitor of Bcl-6 Reduces the Tfh Population in Peripheral Blood, Splenic Germinal Center and Ankle Joints in a Collagen-Induced Arthritis Mouse Model of RA

    Nitasha Bhatia1, Sedrick Bradley2, Cara McLeod1, Gbemi Olayemi1, Robert Quinet1, William E. Davis3, Jerald Zakem4 and Xin Zhang1, 1Ochsner Medical Center, New Orleans, LA, 2Ochsner Clinic Foundation, New Orleans, LA, 3University of Queensland School of Medicine, Brisbane, Australia, 4Ochsner Medical Center, New Orleans, LA

    Background/Purpose: Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic joint inflammation, synovial hyperplasia and progressive destruction of cartilage and bone. T follicular…
  • Abstract Number: 1952 • 2018 ACR/ARHP Annual Meeting

    Experimental Tendinopathy Treatment with SM04755, a Topical Small Molecule Inhibitor of the Wnt Pathway

    Vishal Deshmukh, Timothy Seo and Yusuf Yazici, Samumed, LLC, San Diego, CA

    Background/Purpose: Tendinopathy is an inflammatory and degenerative disorder caused by injuries and overuse. The Wnt pathway is upregulated in chronic tendinopathy and involved in inflammation,…
  • Abstract Number: 500 • 2018 ACR/ARHP Annual Meeting

    Impact of Inflammation and Biologic Treatments on Generation and Progression to Advanced Calcified Coronary Plaques in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth2, Elizabeth Hernandez2 and Matthew Budoff3, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 3Cardiology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose: In early atherogenesis inflammation drives and co-localizes with intimal calcification. In chronic, advanced plaques inflammation and calcification are inversely correlated and spatially distinct; advanced…
  • Abstract Number: 1994 • 2018 ACR/ARHP Annual Meeting

    Osteoarthritis Severity Is Reduced By Intra-Articular Administration of Hydrogen Sulfide

    Elena F. Burguera1,2, Angela Vela-Anero3, Carlos Vaamonde-Garcia3, Tamara Hermida-Gómez1,2, Purificacion Filgueira-Fernandez1,2, Lucía Gato-Calvo2, Rosa Meijide-Failde4 and Francisco J Blanco5, 1CIBER-BBN, Madrid, Spain, 2Unidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Agrupación Estratégica CICA-INIBIC, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), A Coruña, Spain, 3Department of Physiotherapy, Medicine and Biological sciences, Tissue Engineering and Regenerative Medicine group (University of A Coruña), A Coruña, Spain, 4Department of Physiotherapy, Medicine and Biological Sciences, Tissue Engineering and Regenerative Medicine group (University of A Coruña), A Coruña, Spain, 5Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

    Background/Purpose: Hydrogen sulphide (H2S) is recognized as a therapeutic target in osteoarthritis (OA). Exogenous supplementation with synthetic salts in in vitro models of OA has…
  • Abstract Number: 840 • 2018 ACR/ARHP Annual Meeting

    The CCL21/CCR7 Axis Drives Vascular, Inflammatory and Destructive Remodeling in Rheumatoid Arthritis

    Katrien Van Raemdonck1,2, Karol Palasiewicz1,2, Sadiq Umar1,2 and Shiva Shahrara2, 1Jesse Brown VA Medical Center, Chicago, IL, 2Medicine, Division of Rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: The synovial tissue of rheumatoid arthritis (RA) patients exhibits abundant expression of CCL21, produced excessively by RA fibroblasts and macrophages. While CCR7 mediates CCL21-driven…
  • Abstract Number: 2059 • 2018 ACR/ARHP Annual Meeting

    Inhibition of the Transcription Factor That Drives IL-17 Expression Suppresses Inflammation, Joint Damage, and New Bone Formation in Experimental Spondyloarthritis in HLA-B27 Transgenic Rats

    Joel Taurog1, Jiankun Zhu1, Michael Kort2, Shaughn Bryant3, Lucy Phillips3 and Wendy Waegell3, 1Dept Int Med-Rheum Dis Div, University of Texas Southwestern Medical Center, Dallas, TX, 2AbbVie, Inc., North Chicago, IL, 3AbbVie, Inc., Worcester, MA

    Background/Purpose: The IL-17 axis has been identified as a central pathway in SpA pathogenesis. Targeting this axis in AS and PsA significantly suppresses inflammation and…
  • Abstract Number: 845 • 2018 ACR/ARHP Annual Meeting

    New Insights in Lupus Dermatitis: Differential Regulation and Roles of Tissue-Resident Dendritic Cell Subsets in the Pathogenesis of Autoimmune Skin Inflammation

    Ram R. Singh, Miguel-Angel Gutierrez, Peter Kim, Darshan Randhawa, Rachael Philips, Jennifer K. King and Anna Eriksson, Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA

    Background/Purpose: Acquired or self antigens in tissues are taken to lymphoid organs to elicit protective immunity or tolerance, respectively. This is accomplished by dendritic cells…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology